| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cancer genetic testing: applying scientific discovery to clinical practice
|
Senter, Leigha
|
|
2008
|
5 |
12 |
p. 660-664
5 p.
|
artikel
|
| 2 |
Changes in ESA labeling, reimbursement, and utilization: a cautionary tale
|
|
|
2008
|
5 |
12 |
p. 682-
1 p.
|
artikel
|
| 3 |
Closing in on an MOPP for myeloma
|
|
|
2008
|
5 |
12 |
p. 683-684
2 p.
|
artikel
|
| 4 |
Commentary by Debbie Pencarinha, CGC, Kingsport Hematology and Oncolog y Associates, Kingsport, TN
|
|
|
2008
|
5 |
12 |
p. 665-666
2 p.
|
artikel
|
| 5 |
Commentary by Sue Friedman, Executive Director, FORCE, Tampa, FL
|
|
|
2008
|
5 |
12 |
p. 666-
1 p.
|
artikel
|
| 6 |
Finding a place for thrombopoietin receptor agonists in the treatment of chronic ITP
|
Pullarkat, Vinod
|
|
2008
|
5 |
12 |
p. 653-654
2 p.
|
artikel
|
| 7 |
Gene-expression analysis could “change everything” in oncology
|
|
|
2008
|
5 |
12 |
p. 684-
1 p.
|
artikel
|
| 8 |
Helping patients meet their financial obligations: monitoring and benchmarking your collections
|
Pilley, Karen
|
|
2008
|
5 |
12 |
p. 677-680
4 p.
|
artikel
|
| 9 |
Improving patient outcomes with decitabine therapy for myelodysplastic syndromes
|
Davisson, Jan
|
|
2008
|
5 |
12 |
p. 669-673
5 p.
|
artikel
|
| 10 |
IV iron plus ESAs for CIA: a win-win combination
|
|
|
2008
|
5 |
12 |
p. 684-
1 p.
|
artikel
|
| 11 |
Jumping the gun
|
|
|
2008
|
5 |
12 |
p. 665-
1 p.
|
artikel
|
| 12 |
KRAS study opens door to individualized, more cost-effective colorectal cancer therapy
|
|
|
2008
|
5 |
12 |
p. 683-
1 p.
|
artikel
|
| 13 |
Metastatic breast cancer patients: addressing their unmet needs
|
|
|
2008
|
5 |
12 |
p. 645-647
3 p.
|
artikel
|
| 14 |
Prospects for community oncology in 2009 and beyond
|
Okon, Ted A.
|
|
2008
|
5 |
12 |
p. 675-
1 p.
|
artikel
|
| 15 |
Recent trials of NSCLC therapies yield intriguing findings
|
|
|
2008
|
5 |
12 |
p. 682-683
2 p.
|
artikel
|
| 16 |
Romiplostim for treating thrombocytopenia in chronic idiopathic thrombocytopenic purpura (ITP)
|
Abraham, Jame
|
|
2008
|
5 |
12 |
p. 651-652
2 p.
|
artikel
|
| 17 |
Romiplostim: the risk evaluation and mitigation strategy (REMS)
|
Newton, Michael
|
|
2008
|
5 |
12 |
p. 654-655
2 p.
|
artikel
|
| 18 |
Supporting Josephine/Joe the oncologist
|
Bosserman, Linda D.
|
|
2008
|
5 |
12 |
p. 637-
1 p.
|
artikel
|
| 19 |
Supporting patients with metastatic breast cancer: a call to action
|
Gradishar, William J.
|
|
2008
|
5 |
12 |
p. 647-648
2 p.
|
artikel
|
| 20 |
The year's most important developments in cancer treatment
|
|
|
2008
|
5 |
12 |
p. 682-
1 p.
|
artikel
|
Tijdschrift beschrijving